Covestor’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$0 Sell
17
-12
-41% -$202 ﹤0.01% 2599
2026
Q2
$0 Buy
29
+21
+263% +$304 ﹤0.01% 2656
2026
Q1
$0 Buy
8
+5
+167% +$69 ﹤0.01% 2524
2025
Q4
$0 Hold
3
– – ﹤0.01% 2497
2025
Q3
$0 Hold
3
– – ﹤0.01% 2513
2025
Q2
$0 Hold
3
– – ﹤0.01% 2465
2025
Q1
$0 Hold
3
– – ﹤0.01% 2472
2024
Q4
$0 Hold
3
– – ﹤0.01% 2481
2024
Q3
$0 Hold
3
– – ﹤0.01% 2463
2024
Q2
$0 Buy
+3
New +$141 ﹤0.01% 2482

Other funds holding JANX

Covestor's JANX Position: Q3 2026 in Review

Covestor reduced its Janux Therapeutics (JANX) stake by 41% in Q3 2026, selling an estimated $202 and leaving 17 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2599.

Covestor first reported a position in JANX in Q2 2024 and has held it in 10 quarters since. 139 funds tracked by Wall St. Rank hold JANX as of Q3 2026.

  • Covestor held 17 shares of Janux Therapeutics worth $0 as of Q3 2026.
  • Covestor sold 12 Janux Therapeutics shares in Q3 2026, an estimated $202.
  • Janux Therapeutics made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2599 holding.
  • Covestor first reported a position in Janux Therapeutics in Q2 2024 and has held it in 10 quarters since.
  • 139 funds tracked by Wall St. Rank held Janux Therapeutics as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.